MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkaa530

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2021

Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.

Falcone Marco, Tiseo Giusy, Giordano Cesira, Leonildi Alessandro, Menichini Melissa, Vecchione Alessandra, Pistello Mauro, Guarracino Fabio, Ghiadoni Lorenzo, Forfori Francesco, Barnini Simona, Menichetti Francesco, Pisa COVID-19 Study Group

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Bacterial and fungal superinfections may complicate the course of hospitalized patients with COVID-19.

OBJECTIVES

To identify predictors of superinfections in COVID-19.

METHODS

Prospective, observational study including patients with COVID-19 consecutively admitted to the University Hospital of Pisa, Italy, between 4 March and 30 April 2020. Clinical data and outcomes were registered. Superinfection was defined as a bacterial or fungal infection that occurred ≥48 h after hospital admission. A multivariate analysis was performed to identify factors independently associated with superinfections.

RESULTS

Overall, 315 patients with COVID-19 were hospitalized and 109 episodes of superinfections were documented in 69 (21.9%) patients. The median time from admission to superinfection was 19 days (range 11-29.75). Superinfections were caused by Enterobacterales (44.9%), non-fermenting Gram-negative bacilli (15.6%), Gram-positive bacteria (15.6%) and fungi (5.5%). Polymicrobial infections accounted for 18.3%. Predictors of superinfections were: intestinal colonization by carbapenem-resistant Enterobacterales (OR 16.03, 95% CI 6.5-39.5, P < 0.001); invasive mechanical ventilation (OR 5.6, 95% CI 2.4-13.1, P < 0.001); immunomodulatory agents (tocilizumab/baricitinib) (OR 5.09, 95% CI 2.2-11.8, P < 0.001); C-reactive protein on admission >7 mg/dl (OR 3.59, 95% CI 1.7-7.7, P = 0.001); and previous treatment with piperacillin/tazobactam (OR 2.85, 95% CI 1.1-7.2, P = 0.028). Length of hospital stay was longer in patients who developed superinfections ompared with those who did not (30 versus 11 days, P < 0.001), while mortality rates were similar (18.8% versus 23.2%, P = 0.445).

CONCLUSIONS

The risk of bacterial and fungal superinfections in COVID-19 is consistent. Patients who need empiric broad-spectrum antibiotics and immunomodulant drugs should be carefully selected. Infection control rules must be reinforced.

Для цитирования: Falcone Marco, Tiseo Giusy, Giordano Cesira, Leonildi Alessandro, Menichini Melissa, Vecchione Alessandra, Pistello Mauro, Guarracino Fabio, Ghiadoni Lorenzo, Forfori Francesco, Barnini Simona, Menichetti Francesco, Pisa COVID-19 Study Group. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.. The Journal of antimicrobial chemotherapy. 2021. DOI: 10.1093/jac/dkaa530.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.